12:00 AM
Jun 12, 2000
 |  BC Week In Review  |  Company News  |  Deals

Corixa, Medarex deal

MEDX will use its HuMAb-Mouse antibody technology to generate human monoclonal antibodies against targets from CRXA's library of autoimmune disease, cancer and infectious disease antigens. The multi-year...

Read the full 113 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >